Neuroendocrine Tumours with Secondary Liver Lesions

Author(s): Valentina Ambrosini, Davide Campana, Paola Tommassetti and Stefano Fanti

Pp: 120-128 (9)

Abstract

Secondary liver lesions are frequently encountered in neuroendocrine tumours (NET) of the gastro-entero-pancreatic tract. Although conventional morphologic imaging modalities and somatostatin receptor scintigraphy (SRS) have been extensively used in past decades, with the advent of PET/CT, new diagnostic procedures are currently available with the employment of different beta emitting tracers. In fact NET can be easily visualised on PET scans using an array of both metabolic and receptor-based tracers. 3,4-dihydroxy-6-[¹⁸F]fluoro-L-phenylalanine (¹⁸F-DOPA) and ⁶⁸Ga-DOTApeptides (DOTA-TOC, DOTA-NOC, DOTA-TATE) are very promising to image well-differentiated NET and were reported to be superior to other imaging modalities (CT, SRS). On the contrary, the role of ¹⁸F-FDG is limited in well-differentiated NET, due to their low glucose metabolism and growth rate, while it can still provide valuable information in less differentiated NET or in forms with lower expression of somatostatin receptors.

Keywords: PET; CT; Neuroendocrine tumours; ¹⁸F-FDG; ¹⁸F-DOPA; ⁶⁸Ga-DOTA-peptides

Cite as